Thurston, Springer, Miller, Herd & Titak, Inc. Eli Lilly & CO Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 13,085 shares of LLY stock, worth $10.3 Million. This represents 2.13% of its overall portfolio holdings.
Number of Shares
13,085
Previous 10,443
25.3%
Holding current value
$10.3 Million
Previous $9.25 Million
9.19%
% of portfolio
2.13%
Previous 2.81%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,033Shares Held
737MCall Options Held
8.26MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$76.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$57.9 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$51.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.3 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$26.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $746B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...